Concepedia

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Charlotte M. Huijts, Saskia J. Santegoets, Alfons J. van den Eertwegh, Laura S Pijpers, John B.A.G. Haanen, Tanja D. de Gruijl, Henk M.W. Verheul, Hans van Vliet

BMC Cancer · 2011 · 28 citations · 26 references

DOIFull text

Open access

Abstract

ClinicalTrials.gov Identifier NCT01462214, EudraCT number 2010-024515-13, Netherlands Trial Register number NTR3085.

References

26

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.3K citations

, , +16

Cancer: Principles and Practice of Oncology.

Annals of Internal Medicine · 1991 · 8.5K citations

, , +14

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.7K citations · Full text

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · The Lancet · 2008 · 3K citations

, , +5

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Timothy M. Browder, Catherine Butterfield, Birgit M. Kräling et al. · PubMed · 2000 · 1.6K citations

, , +14